Dana Narvaez, MD

113 posts

Dana Narvaez, MD banner
Dana Narvaez, MD

Dana Narvaez, MD

@narvaezdanap

Oncologist- Instituto Alexander Fleming, Buenos Aires. Doing, learning, sharing

Ciudad Autónoma de Buenos Aire Katılım Kasım 2021
734 Takip Edilen435 Takipçiler
Sabitlenmiş Tweet
Dana Narvaez, MD
Dana Narvaez, MD@narvaezdanap·
Proud to receive the IDEA Award from @ASCO @ConquerCancerFd . Thank you for supporting young oncologists from around the world working to make a difference
Dana Narvaez, MD tweet media
English
5
1
65
3.3K
Dana Narvaez, MD
Dana Narvaez, MD@narvaezdanap·
✨Excited to share our new review on post-CDK4/6i treatment sequencing in HR+/HER2− metastatic breast cancer is out in @IJMS_MDPI 🔬 🧬Exploring biomarker-driven strategies and emerging therapies mdpi.com/1422-0067/26/2…
English
0
1
11
288
Dana Narvaez, MD retweetledi
Yakup Ergün
Yakup Ergün@dr_yakupergun·
#ESMO25 Managing HR+/HER2– mBC in 2025 💬An update is likely following the evERA and VIKTORIA-1 trials From Dr. William Gradishar's presentation👇
Yakup Ergün tweet media
English
8
99
249
15.2K
Dana Narvaez, MD retweetledi
Prof. Feynman
Prof. Feynman@ProfFeynman·
The most powerful tool of your mind is not its capacity to know, but its ability to question.
English
42
335
1.6K
77K
Dana Narvaez, MD
Dana Narvaez, MD@narvaezdanap·
🚨 Out now in @TAMedOncol! 💡 Our LATAM study reveals strong heterogeneity in treatment decisions for young women with HR+/HER2– early breast cancer — influenced by physician specialty, gender & resource availability. 17 countries 🇦🇷🇲🇽🇪🇨🇨🇴🇻🇪🇵🇾🇨🇱🇵🇪🇨🇺 🔗 doi.org/10.1177/175883…
English
0
1
3
191
Dana Narvaez, MD
Dana Narvaez, MD@narvaezdanap·
HR+/HER2– advanced breast cancer after CDK4/6i progression: ideal scenarios vs real-world access to therapies in global oncology 📍 Patagonian Breast Cancer Congress 🎤 Talk by Dr. @ggabuin @SUMAargentina @aaoncoclinica
Dana Narvaez, MD tweet media
English
0
1
7
437
Dana Narvaez, MD retweetledi
Tim Cook
Tim Cook@tim_cook·
It’s hard to believe it’s been 20 years since Steve told Stanford graduates to stay hungry and stay foolish. His powerful advice still rings true, and I hope it helps guide this year’s new grads as they begin their journey to become tomorrow’s leaders. stevejobsarchive.com/exhibits/stay-…
English
618
1.6K
11.2K
831.5K
Dana Narvaez, MD retweetledi
Chiara Corti
Chiara Corti@CCortiMD·
Pleased to share the first series of pts who experienced recurrence on adjuvant abemaciclib+ET: ➤ 9.2% (15/163) recurred ➤ 50% ER loss post-tx ➤ 90% TP53-pathway alterations post-tx ➤ Median 1L m+ tx duration: 3.0 mo (IQR 1.6–5.0) shorturl.at/ZnMI5
Chiara Corti tweet media
English
5
35
101
20.7K
Dana Narvaez, MD
Dana Narvaez, MD@narvaezdanap·
Today at Brown, we had the honor of listening to Dr. @DrSGraff powerful talk on influential leadership. I deeply admire her ability to lead with both scientific excellence and profound human connection @ConquerCancerFd @BrownUCancer
Dana Narvaez, MD tweet media
English
5
2
16
919
Dana Narvaez, MD
Dana Narvaez, MD@narvaezdanap·
#ASCO25 Dr. Mukhtar presented I-SPY2 data showing ctDNA as a potential predictor of nodal burden after neoadjuvant therapy. Promising steps toward more personalized, biology-driven treatment decisions.
Dana Narvaez, MD tweet media
English
0
3
8
751
Paola Zagami, MD
Paola Zagami, MD@paolazagam·
It was a great honor to meet @KalinskyKevin,amazing oncologist and beautiful person! Thanks a lot for your and dr Keir support, endorsing my ASCO conquer cancer merit awar🏅. Great and interesting presentation of NATALEE trial by age and menopausal! @ConquerCancerFd #ASCO25
Paola Zagami, MD tweet media
Chicago, IL 🇺🇸 English
4
2
26
999
Dana Narvaez, MD
Dana Narvaez, MD@narvaezdanap·
📍ASCO25 – Day 3 Powerful presentation by Dr Turner on the long-awaited SERENA-6 trial. Dr @AngieDemichele delivered a super interesting analysis of its clinical utility Is ctDNA redefining the landscape of breast cancer care? Exciting times ahead for precision oncology 👏
Dana Narvaez, MD tweet mediaDana Narvaez, MD tweet media
English
0
0
4
226